Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanzheng Liang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|July 18, 2022
Shaping Polarization Of Tumor-Associated Macrophages In Cancer ImmunotherapyJing Gao, Yuanzheng Liang, Liang Wang
Chinese Medical Journal|March 20, 2023
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphomaRuiying Fu, Yuanzheng Liang, Liqiang Wei, et al.
Chinese Medical Journal|February 13, 2023
Dose-adjusted EPOCH-R vs. R-CHOP in frontline management of Waldeyer's ring diffuse large B-cell lymphoma: a retrospective study from a single institutionYuanzheng Liang, Xindi Liu, Jing Yang, et al.
The Journal of Dermatology|May 13, 2021
Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in ChinaXinhua Wang, Yuanzheng Liang, Yanxin Yang, et al.
Cancer Medicine|March 16, 2023
A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphomaXindi Liu, Yuanzheng Liang, Ziyuan Shen, et al.
Cancer Medicine|July 30, 2022
Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort studyYuanzheng Liang, Rui-Ying Fu, Xue-Lin Liu, et al.
Journal of Translational Medicine|March 20, 2026
Efficacy and safety analysis of CAR-T cell salvage therapy in relapsed/refractory diffuse large B-cell lymphoma after failure of bispecific antibody treatmentFuli Li, Henan Wang, Yuanzheng Liang, et al.
Molecular Cancer|September 21, 2022
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogrammingYuanzheng Liang, Haiyan He, Weida Wang, et al.
Leukemia|March 20, 2024
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphomaLin-Rui Gao, Xin Li, Xinyue Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|July 18, 2022
Shaping Polarization Of Tumor-Associated Macrophages In Cancer ImmunotherapyJing Gao, Yuanzheng Liang, Liang Wang
Chinese Medical Journal|March 20, 2023
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphomaRuiying Fu, Yuanzheng Liang, Liqiang Wei, et al.
Chinese Medical Journal|February 13, 2023
Dose-adjusted EPOCH-R vs. R-CHOP in frontline management of Waldeyer's ring diffuse large B-cell lymphoma: a retrospective study from a single institutionYuanzheng Liang, Xindi Liu, Jing Yang, et al.
The Journal of Dermatology|May 13, 2021
Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in ChinaXinhua Wang, Yuanzheng Liang, Yanxin Yang, et al.
Cancer Medicine|March 16, 2023
A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphomaXindi Liu, Yuanzheng Liang, Ziyuan Shen, et al.
Cancer Medicine|July 30, 2022
Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort studyYuanzheng Liang, Rui-Ying Fu, Xue-Lin Liu, et al.
Journal of Translational Medicine|March 20, 2026
Efficacy and safety analysis of CAR-T cell salvage therapy in relapsed/refractory diffuse large B-cell lymphoma after failure of bispecific antibody treatmentFuli Li, Henan Wang, Yuanzheng Liang, et al.
Molecular Cancer|September 21, 2022
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogrammingYuanzheng Liang, Haiyan He, Weida Wang, et al.
Leukemia|March 20, 2024
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphomaLin-Rui Gao, Xin Li, Xinyue Wang, et al.
Pageof 1